Filament Health Corp.

About Filament Health Corp.

Filament Health is dedicated to providing safe, naturally-derived psychedelic medicines to help millions of people suffering from mental health conditions worldwide, with a mission to make these treatments accessible as soon as possible.

Products & Services

Naturally-Derived Psychedelic Medicines:Pharmaceutical-grade botanical psychedelics developed from natural compounds, leveraging unique development pathways for speed, efficacy, and access to both pharmaceutical and non-pharmaceutical markets.

Specialties

Naturally-Derived Psychedelics Botanical Drug Development Mental Health Treatments Psilocybin Access Programs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Issuance T: - FT: Equity Issuance	A: 280000 MR: - FA: 280,000 USD FAN: 280000	D: 2024-10-04 FD: 2024-10-04	3 investors
2	RT: Bridge Financing and Private Placement T: - FT: Bridge Financing and Private Placement	A: 730000 MR: - FA: C$1.0 million FAN: 730000	D: 2024-06-12 FD: 2024-06-12	1 investors
3	RT: Bridge Financing T: - FT: Bridge Financing	A: 730000 MR: - FA: C$1.0 million FAN: 730000	D: 2024-06-03 FD: 2024-06-03	2 investors
4	RT: Convertible Note T: - FT: Convertible Note	A: 14400000 MR: - FA: USD$14,400,000 FAN: 14400000	D: 2023-12-06 FD: 2023-12-06	2 investors
5	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 2000000 MR: - FA: up to C$2,000,000 FAN: 2000000	D: 2023-09-29 FD: 2023-09-29	1 investors
6	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 2500000 MR: - FA: C$2,500,000 FAN: 2500000	D: 2023-07-24 FD: 2023-07-24	1 investors
7	RT: Private Placement T: - FT: Private Placement	A: 2000000 MR: - FA: C$2,000,000 FAN: 2000000	D: 2023-07-19 FD: 2023-07-19	1 investors

Equity Issuance Latest

2024-10-04

$280K

3 investors (Pro only)

Bridge Financing and Private Placement 2024-06-12

$730K

Bridge Financing 2024-06-03

$730K

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Benjamin Lightburn

Chief Executive Officer and Co-Founder

L

Lisa Ranken

Chief Operating Officer

S

Steven Nguyen

Interim Chief Financial Officer

R

Ryan Moss

Chief Science Officer

A

Andry Tjahyana

Vice President, Business Development

A

Anna Cordon

Vice President, Marketing & Communications

View 14 more team members with Pro

Unlock Full Team Directory

Recent News